ALKERMES | Resultado Líquido

Net Income Alterar Data
AbbVie USD 822M 956M 2023-12
Acadia Pharmaceuticals USD 45.8M 110.97M 2023-12
ALKERMES USD 47.76M 189.31M 2023-09
Amgen USD 767M 963M 2023-12
Biogen USD 249.7M 317.8M 2023-12
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Bluebird Bio USD -71731000 1.18M 2023-09
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Eli Lilly USD 2.19B 2.25B 2023-12
Gilead Sciences USD 1.43B 751M 2023-12
Heron Therapeutics USD -25008000 17.05M 2023-09
Intra Cellular Therapies USD -28579000 4.32M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Malin Corporation EUR 1.1M 10.6M 2023-06
Marinus Pharmaceuticals USD -32972000 1.04M 2023-09
Merck USD -1226000000 5.97B 2023-12
Minerva Neurosciences USD -7821000 1.63M 2023-09
Nektar Therapeutics USD -45837000 5.28M 2023-09
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Otsuka Holdings JPY 59.12B 17.96B 2023-09
Ovoca Bio EUR -5652000 3.28M 2022-06
Pfizer USD -3368000000 986M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Revance Therapeutics USD -141176000 73.86M 2023-09
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



ALKERMES Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.